Tumor-infiltrating Lymphocyte Subsets and Tertiary Lymphoid Structures in Pulmonary Metastases from Colorectal Cancer

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2016 Jul 25

PMID 27449756

Citations 59

Authors

Thomas Schweiger

Anna Sophie Berghoff

Christoph Glogner

Olaf Glueck

Orsolya Rajky

Denise Traxler

Peter Birner

Matthias Preusser

Walter Klepetko

Konrad Hoetzenecker

Affiliations

Soon will be listed here.

Abstract

The presence of tumor-infiltrating lymphocytes (TILs) and tertiary lymphoid structures (TLSs) reflects an active inflammatory tumor microenvironment. High density of TILs as well as presence of TLS is associated with improved survival in various solid cancer types. We aimed to describe the density and distribution of TILs and TLS in pulmonary metastases (PMs) from primary colorectal cancer (CRC) and its correlation with clinicopathological variables. Fifty-seven CRC pulmonary metastasectomy specimen (PM) and 31 matched primary CRC specimen were included. Cluster of differentiation (CD)3+, CD8+, CD45RO+ and FoxP3+ TILs were evaluated by immunohistochemistry and density was scored semiquantitatively. TLS were evaluated based on morphological criteria. Survival time was defined from pulmonary metastasectomy to death or last follow up. A marked infiltration with CD3+, CD8+, CD45RO+ and FoxP3+ TILs was evident in CRC PM and matched primary CRC. Further assessment of the immune infiltrate in PM showed that a high density of FOXP3+ TILs at the invasive margin [HR 2.40 (1.11-6.96); P = 0.031] and low density of CD8+ cells in TLS [HR 0.30 (0.14-0.79); P = 0.016] were associated with a worse prognosis in univariate analysis. Moreover, a low CD8/FoxP3-ratio of TILs at the invasive margin (P = 0.042) and in TLS (P = 0.027) conferred an impaired prognosis after pulmonary metastasectomy. Our findings suggest that CRC PM harbor an immune active microenvironment. The balance of CD8+ and FoxP3+ T-cells at the tumor border and in TLS provides prognostic information in patients with CRC PM.

Citing Articles

Tertiary lymphoid structures in colorectal cancer - organization and immune cell interactions.

Gulubova M, Valkanov S, Ignatova M, Minkov G Am J Clin Exp Immunol. 2025; 13(6):236-245.

PMID: 39839346 PMC: 11744347. DOI: 10.62347/GRYY2849.

The global trends and distribution in tumor-infiltrating lymphocytes over the past 49 years: bibliometric and visualized analysis.

Wu B, Luo D, Wang X, Qiao C, Li R, Liu J Front Immunol. 2025; 15():1511866.

PMID: 39835135 PMC: 11743541. DOI: 10.3389/fimmu.2024.1511866.

[Clinical significance of tertiary lymphoid structure maturity in colorectal cancer patients].

Zheng J, Yu J, Xie J, Chen D, Deng H Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024; 53(6):765-771.

PMID: 39628410 PMC: 11736343. DOI: 10.3724/zdxbyxb-2024-0320.

Tertiary lymphoid structures in colorectal cancer.

Lv J, Zhang X, Zhou M, Yan J, Chao G, Zhang S Ann Med. 2024; 56(1):2400314.

PMID: 39575712 PMC: 11616745. DOI: 10.1080/07853890.2024.2400314.

Machine Vision-Detected Peritumoral Lymphocytic Aggregates Are Associated With Disease-Free Survival in Patients With Papillary Thyroid Carcinoma.

Monabbati S, Fu P, Asa S, Pathak T, Willis J, Shi Q Lab Invest. 2024; 104(12):102168.

PMID: 39505213 PMC: 11659025. DOI: 10.1016/j.labinv.2024.102168.

References

Suzuki H, Chikazawa N, Tasaka T, Wada J, Yamasaki A, Kitaura Y . Intratumoral CD8(+) T/FOXP3 (+) cell ratio is a predictive marker for survival in patients with colorectal cancer. Cancer Immunol Immunother. 2009; 59(5):653-61. PMC: 11030791. DOI: 10.1007/s00262-009-0781-9. View

Nishikawa H, Kato T, Tawara I, Takemitsu T, Saito K, Wang L . Accelerated chemically induced tumor development mediated by CD4+CD25+ regulatory T cells in wild-type hosts. Proc Natl Acad Sci U S A. 2005; 102(26):9253-7. PMC: 1166632. DOI: 10.1073/pnas.0503852102. View

Renaud S, Falcoz P . How can we identify new biomarkers for patients with for lung metastasectomy in colorectal cancer. Future Oncol. 2015; 11(15):2109-11. DOI: 10.2217/fon.15.124. View

Nesbeth Y, Conejo-Garcia J . Harnessing the effect of adoptively transferred tumor-reactive T cells on endogenous (host-derived) antitumor immunity. Clin Dev Immunol. 2010; 2010:139304. PMC: 2975067. DOI: 10.1155/2010/139304. View

Koelzer V, Lugli A, Dawson H, Hadrich M, Berger M, Borner M . CD8/CD45RO T-cell infiltration in endoscopic biopsies of colorectal cancer predicts nodal metastasis and survival. J Transl Med. 2014; 12:81. PMC: 4022053. DOI: 10.1186/1479-5876-12-81. View

Miyashita M, Sasano H, Tamaki K, Hirakawa H, Takahashi Y, Nakagawa S . Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study. Breast Cancer Res. 2015; 17:124. PMC: 4560879. DOI: 10.1186/s13058-015-0632-x. View

Junttila M, de Sauvage F . Influence of tumour micro-environment heterogeneity on therapeutic response. Nature. 2013; 501(7467):346-54. DOI: 10.1038/nature12626. View

Mlecnik B, Tosolini M, Kirilovsky A, Berger A, Bindea G, Meatchi T . Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011; 29(6):610-8. DOI: 10.1200/JCO.2010.30.5425. View

Owusu B, Vaid M, Kaler P, Klampfer L . Prognostic and Predictive Significance of Stromal Fibroblasts and Macrophages in Colon Cancer. Biomark Cancer. 2015; 7(Suppl 1):29-37. PMC: 4631158. DOI: 10.4137/BIC.S25247. View

10.

Berghoff A, Lassmann H, Preusser M, Hoftberger R . Characterization of the inflammatory response to solid cancer metastases in the human brain. Clin Exp Metastasis. 2012; 30(1):69-81. DOI: 10.1007/s10585-012-9510-4. View

11.

Donnem T, Hald S, Paulsen E, Richardsen E, Al-Saad S, Kilvaer T . Stromal CD8+ T-cell Density—A Promising Supplement to TNM Staging in Non-Small Cell Lung Cancer. Clin Cancer Res. 2015; 21(11):2635-43. DOI: 10.1158/1078-0432.CCR-14-1905. View

12.

Galon J, Mlecnik B, Bindea G, Angell H, Berger A, Lagorce C . Towards the introduction of the 'Immunoscore' in the classification of malignant tumours. J Pathol. 2013; 232(2):199-209. PMC: 4255306. DOI: 10.1002/path.4287. View

13.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

14.

Nishikawa H, Kato T, Tanida K, Hiasa A, Tawara I, Ikeda H . CD4+ CD25+ T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc Natl Acad Sci U S A. 2003; 100(19):10902-6. PMC: 196900. DOI: 10.1073/pnas.1834479100. View

15.

Halama N, Spille A, Lerchl T, Brand K, Herpel E, Welte S . Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration. Oncoimmunology. 2013; 2(4):e24116. PMC: 3654605. DOI: 10.4161/onci.24116. View

16.

Hanke T, Melling N, Simon R, Sauter G, Bokemeyer C, Lebok P . High intratumoral FOXP3⁺ T regulatory cell (Tregs) density is an independent good prognosticator in nodal negative colorectal cancer. Int J Clin Exp Pathol. 2015; 8(7):8227-35. PMC: 4555719. View

17.

Caro G, Bergomas F, Grizzi F, Doni A, Bianchi P, Malesci A . Occurrence of tertiary lymphoid tissue is associated with T-cell infiltration and predicts better prognosis in early-stage colorectal cancers. Clin Cancer Res. 2014; 20(8):2147-58. DOI: 10.1158/1078-0432.CCR-13-2590. View

18.

Lee W, Park S, Lee W, Yun S, Chun H . Clinical impact of tumor-infiltrating lymphocytes for survival in stage II colon cancer. Cancer. 2010; 116(22):5188-99. DOI: 10.1002/cncr.25293. View

19.

Giraldo N, Becht E, Pages F, Skliris G, Verkarre V, Vano Y . Orchestration and Prognostic Significance of Immune Checkpoints in the Microenvironment of Primary and Metastatic Renal Cell Cancer. Clin Cancer Res. 2015; 21(13):3031-40. DOI: 10.1158/1078-0432.CCR-14-2926. View

20.

Zou W . Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol. 2006; 6(4):295-307. DOI: 10.1038/nri1806. View